HCPLive Network

In Young People, Sudden Cardiac Death can be Caused by Gene Defects

Researchers from Germany’s Institute for Forensic Medicine have discovered that ion channel disorders like long QT syndromes, catecholaminergic polymorphic ventricular tachycardia, and the Brugada syndrome may account for one-third of unexplainable sudden cardiac death (SCD) in young people.

The researchers subcategorized cardiac gene defects into two groups: disorders that are accompanied by structural cardiovascular abnormalities, such as arrhythmogenic right ventricular dysplasia and hypertrophic cardiomyopathy; and disorders that do not have cardiac changes detectable at the time of death with a cause that is mostly arrhythmogenic, like the ion channels responsible for one-third of the SCD cases in young people.

The team of researchers found that post-mortem genetic screening for the presence of sequence variations in cardiac ion channel genes was helpful in ascertaining the cause of SCD in otherwise unclear cases.

SCD is listed as one of the most common causes of death in Europe, and although it usually happens among older people, 5-10% of cases there occur in young and apparently healthy people. The study adds that as many as 7,000 asymptomatic children in the US die from SCD each year, almost half of whom never show earlier symptoms.

In their findings, the researchers discussed that the majority of the ion-channel diseases are hereditary with an autosomal-dominant transmission, meaning that half of the children of individuals affected by SCD will be impacted as well.

In the event that sequence variations are identified, family members of the deceased should then undergo further medical tests. The researchers hope that these new findings will allow for individual risk analysis among impacted family members, who can then be provided with prophylactic treatment, such as an implantable cardioverter defibrillator.

For more information, click here.
Further Reading
A defined process is necessary to help physicians hire the right staff for their practice, according to an article published July 24 in Medical Economics.
A defined process is necessary to help physicians hire the right staff for their practice, according to an article published July 24 in Medical Economics.
The Artist’s Colony is a must-see attraction; for travelers near Southern Germany, Mathildenhöhe is an open air Art Noveau museum that delights.
When it was approved by the FDA in March 2014, apremilast became the first oral medication approved for the treatment of psoriatic arthritis (PsA). Data from clinical trials showed it to be an effective option for patients, with a safer side effect profile than currently used PsA treatments.
As more pediatric surgical procedures being conducted as same-day procedures, parents are assuming responsibility for their children’s immediate post-operative pain management.
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
There is a significantly increased risk of cardiac death associated with clarithromycin use, according to a study published online Aug. 19 in BMJ.
More Reading